Published in Can J Plast Surg on January 01, 2011
Lipodystrophies. Am J Med (2000) 2.44
Full scope of effect of facial lipoatrophy: a framework of disease understanding. Dermatol Surg (2006) 2.01
Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS (2003) 1.97
A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg (2003) 1.93
Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res (1993) 1.72
Fat distribution: a morphologic study of the aging face. Dermatol Surg (2000) 1.65
The wrinkle severity rating scale: a validation study. Am J Clin Dermatol (2004) 1.63
Relationship between lipoatrophy and quality of life. AIDS Read (2005) 1.40
Cutaneous effects of smoking. J Cutan Med Surg (2005) 1.13
Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg (2008) 1.13
Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg (2005) 1.09
Degradation of and tissue reaction to biodegradable poly(L-lactide) for use as internal fixation of fractures: a study in rats. Biomaterials (1991) 1.07
Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstr Surg (2004) 1.05
Nonanimal stabilized hyaluronic acid for lip augmentation and facial rhytid ablation. Arch Facial Plast Surg (2004) 1.04
Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg (2006) 1.03
Injectable skin fillers. Clin Plast Surg (2005) 1.03
Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med (2006) 1.02
An overview of permanent and semipermanent fillers. Plast Reconstr Surg (2006) 1.02
Principles of soft tissue augmentation for the aging face. Clin Interv Aging (2006) 1.01
Long-term tissue response to bioabsorbable poly-L-lactide and metallic screws: an experimental study. Bone (2006) 1.00
A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med (2004) 0.98
Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg (2006) 0.95
Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg (2008) 0.93
Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg (2006) 0.92
A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol (2010) 0.88
Collagen fillers. Dermatol Ther (2006) 0.87
Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg (2009) 0.87
Changes associated with the aging face. Facial Plast Surg Clin North Am (2005) 0.86
Sculptra (injectable poly-L-lactic acid). Facial Plast Surg Clin North Am (2007) 0.85
Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg (2005) 0.84
Poly-L-lactic acid for facial lipoatrophy in HIV. Ann Pharmacother (2006) 0.82
Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol (2004) 0.82
Optimizing poly-L-lactic acid use. J Cosmet Laser Ther (2008) 0.82
Skin rejuvenation without a scalpel. I. Fillers. J Cosmet Dermatol (2006) 0.81
Volume loss versus gravity: new concepts in facial aging. Curr Opin Otolaryngol Head Neck Surg (2007) 0.81
Sculptra: the new three-dimensional filler. Clin Plast Surg (2006) 0.80
CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg (2004) 0.80
Response of articular cartilage and subchondral bone to internal fixation devices made of poly-L-lactide: a histomorphometric and microradiographic study on rabbits. Biomaterials (2000) 0.80
Use of sculptra mark in esthetic rejuvenation. Semin Cutan Med Surg (2006) 0.78
The long-term behavior of poly-L-lactide screws in a minipig fracture model: preliminary report. J Biomed Mater Res (2002) 0.78
Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther (2006) 0.78
Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol (2008) 0.78
Facial dermal fillers. Aesthet Surg J (2008) 0.77
Tobacco use and skin disease. South Med J (2001) 0.77
Cosmetic procedures for the aging face. Clin Geriatr Med (2006) 0.76
Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. J Am Acad Dermatol (2009) 0.76
A protocol for facial volume restoration with poly-L-lactic acid. J Drugs Dermatol (2006) 0.76
Poly-L-lactic acid as a facial filler. Skin Therapy Lett (2005) 0.76
Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: a review of the clinical studies. Int J STD AIDS (2006) 0.76
Update on facial aging. Aesthet Surg J (2010) 0.97
Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg (2006) 0.87
Nonsurgical modalities to treat the aging face. Aesthet Surg J (2010) 0.78
Appropriate selection and application of nonsurgical facial rejuvenation agents and procedures: panel consensus recommendations. Aesthet Surg J (2010) 0.75
Facial aesthetic analysis. Aesthet Surg J (2010) 0.75
Discuss injectable shaping agents within the context of the established and emerging concepts of facial aging. Introduction. Aesthet Surg J (2010) 0.75
Surgical versus nonsurgical rejuvenation. Aesthet Surg J (2010) 0.75